Therapeutic Vaccination With Dendritic Cells Loaded With Autologous HIV Type 1–Infected Apoptotic Cells-Reference-Cited by-同舟云学术

Therapeutic Vaccination With Dendritic Cells Loaded With Autologous HIV Type 1–Infected Apoptotic Cells

Published:2015-12-08 Issue:9 Volume:213 Page:1400-1409
ISSN:0022-1899
Container-title:Journal of Infectious Diseases
language:en
Short-container-title:J Infect Dis.

Author:

Macatangay Bernard J. C.,Riddler Sharon A.,Wheeler Nicole D.,Spindler Jonathan,Lawani Mariam,Hong Feiyu,Buffo Mary J.,Whiteside Theresa L.,Kearney Mary F.,Mellors John W.,Rinaldo Charles R.

Funder

National Institutes of Health

Leidos Biomedical Research, and the National Cancer Institute

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Immunology and Allergy

Link

http://academic.oup.com/jid/article-pdf/213/9/1400/17410966/jiv582.pdf

Reference30 articles.

1. Low-level viremia persists for at least 7 years in patients on suppressive antiretroviral therapy

2. Predictors of residual viremia in patients on long-term suppressive antiretroviral therapy

3. Stimulation of HIV-1-Specific Cytolytic T Lymphocytes Facilitates Elimination of Latent Viral Reservoir after Virus Reactivation

4. Immunobiology of Dendritic Cells

5. Dendritic Cells Reveal a Broad Range of MHC Class I Epitopes for HIV-1 in Persons with Suppressed Viral Load on Antiretroviral Therapy

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Apoptotic bodies: bioactive treasure left behind by the dying cells with robust diagnostic and therapeutic application potentials;Journal of Nanobiotechnology;2023-07-12

2. Dendritic Cells - Winning the Fight against HIV;Current Stem Cell Research & Therapy;2023-02

3. Development of therapeutic vaccines for the treatment of diseases;Molecular Biomedicine;2022-12-08

4. A Tale of Three Recent Pandemics: Influenza, HIV and SARS-CoV-2;Frontiers in Microbiology;2022-06-02

5. Immunogenicity of personalized dendritic-cell therapy in HIV-1 infected individuals under suppressive antiretroviral treatment: interim analysis from a phase II clinical trial;AIDS Research and Therapy;2022-01-12